Summary: Glutathione S-transferases (GSTs) play a vital role in the phase II biotransformation of many chemicals, including anticancer drugs. In this study, to elucidate the haplotype structures of the two closely related alpha-class genes GSTA1 and GSTA2, we screened for genetic variation in 214 Japanese colorectal cancer patients who received oxaliplatin-based chemotherapy. By direct resequencing of the 5¤-flanking region, all the exons, and their flanking introns for 107 patients, 29 and 27 variants were identified in GSTA1 and GSTA2, respectively. The known functional single nucleotide polymorphisms (SNPs) ¹567T>G, ¹69C>T, and ¹52G>A in GSTA1*B were found at allele frequencies of 0.140. Of the four major GSTA2 allelic variants reported previously (GSTA2*A, *B, *C, and *E), only GSTA2*B (frequency = 0.154), *C (0.706), and *E (0.140) were detected. Following linkage disequilibrium analysis, haplotypes of both genes were separately estimated. Then, rapid genotyping methods for 7 and 6 SNPs tagging common haplotypes of GSTA1 and GSTA2, respectively, were developed using the single-base extension assay, and an additional 107 patients were genotyped. Finally, haplotype combinations of both genes were classified into 3 major types: GSTA1*A-GSTA2*C, GSTA1*A-GSTA2*B, and GSTA1*B-GSTA2*E. These findings will be useful in pharmacogenomic studies on xenobiotics including anticancer drugs.
Introduction
Glutathione S-transferases ¤GSTs¥ ¤EC 2.5.1.18¥ are dimeric phase II metabolic enzymes that mainly catalyze conjugation of reduced glutathione ¤GSH¥ with a variety of electrophilic compounds including carcinogens, therapeutic drugs, environmental chemicals, and endogenous substances. 1¥ At present, seven distinct classes of soluble cytoplasmic GSTs have been identified in humans: alpha ¤A¥, mu ¤M¥, omega ¤O¥, pi ¤P¥, sigma ¤S¥, theta ¤T¥, and zeta ¤Z¥.
2,3¥ Among GSTs, the alpha class isoenzymes GSTA1 and GSTA2 are the most abundantly found in human liver and play an important role in metabolic detoxification processes.
The human alpha class genes are localized on chromosome 6p12 and comprise five functional genes ¤GSTA1®GSTA5¥ and seven pseudogenes. 4¥ Human tissues widely express transcripts for GSTA1, A2, and A4, whereas expression of GSTA3 is low and restricted in distribution. GSTA5 has not yet been detected in human tissues. Four alpha class enzymes ¤GSTA1-1, GSTA2-2, GSTA3-3, and GSTA4-4 homodimers¥ show remarkably different substrate specificities.
2¥
Although GSTA1-1 and GSTA2-2 share about 95% amino acid identity, GSTA2-2 seems to exhibit a smaller range of substrate preference and reduced catalytic activities compared with GSTA1-1. For example, the catalytic efficiencies of GSTA2-2 toward the carcinogens ¤¦¥-anti-benzoªa«-pyrene-7,8-diol-9,10-epoxide and 1-chloro-2,4-dinitrobenzene ¤CDNB¥ were 5-fold lower than those of GSTA1-1. 5¥ Similarly, the busulfan-GSH conjugation activity of GSTA2-2 was lower than 10% of that of GSTA1-1. 6¥ It has been shown that both GSTA1 and GSTA2 genes are polymorphic. 7¥ Two alternate alleles ¤GSTA1*A and GSTA1*B¥ have been characterized as a major source of genetic variation in the GSTA1 gene. 8¥ The two alleles differ in nucleotide positions %567, %69, and %52 from the estimated transcriptional initiation site. Specifically, the %52GhA substitution in an SP1-responsive element within the proximal promoter region was shown to have a lowered promoter activity in GSTA1*B in vitro. 4¥ Indeed, livers from individuals who carried the GSTA1*B allele exhibited reduced levels of GSTA1 enzyme. 8¥ On the other hand, GSTA2 is known to have five alleles, GSTA2*A to *E, with variants in exons 5®7.
9,10¥ These alleles differ at the following nucleotide and amino acid positions; GSTA2*A ª328C ¤Pro110¥, 335G ¤Ser112¥, 588G ¤Lys196¥, and 629A ¤Glu210¥«, GSTA2*B ª328C ¤Pro110¥, 335G ¤Ser112¥, 588G ¤Lys196¥, and 629C ¤Ala210¥«, GSTA2*C ª328C ¤Pro110¥, 335C ¤Thr112¥, 588G ¤Lys196¥, and 629A ¤Glu210¥«, GSTA2*D ª328C ¤Pro110¥, 335G ¤Ser112¥, 588T ¤Asn196¥, and 629C ¤Ala210¥«, and GSTA2*E ª328T ¤Ser110¥, 335G ¤Ser112¥, 588G ¤Lys196¥, and 629A ¤Glu210¥«. The catalytic activities of GSTA2 variants A, B, and C do not seem to differ for several substrates in vitro.
9,10¥
Variant E, in which the conserved Pro110 residue is replaced by Ser, showed a reduced specific activity toward several substrates when compared with variants A to C. 10,11¥ In addition, hepatic expression of the Ser112 variants ¤homozygotes of any one of GSTA2*A, *B, or *E¥ was approximately four-fold higher than that of the Thr112 variant ¤homozygote of GSTA2*C¥ in Caucasians.
Interestingly, close associations between GSTA1 and GSTA2 alleles were observed in Caucasians but not in African-Americans. In Caucasians, but not in AfricanAmericans, GSTA1*A is linked with GSTA2*C, and GSTA1*B is linked with GSTA2*A, GSTA2*B, or GSTA2*E. 10¥ The distributions of GSTA1 and GSTA2 polymorphisms and their linkage disequilibrium ¤LD¥ have not been extensively analyzed in Asian populations, including the Japanese.
Several studies have implicated the correlation of the polymorphisms in alpha class GSTs with the susceptibility to cancer and the outcome of chemotherapy. It was reported that individuals who are homozygous for GSTA1*B ¤low hepatic expression¥ have an increased ¤two-fold¥ risk of developing colorectal cancer, possibly as a result of inefficient hepatic detoxification of food-derived heterocyclic amines.
12,13¥ However, other groups have reported controversial findings, where no associations were observed between GSTA1 genotypes and susceptibility to colorectal cancer. 14¥ In breast cancer patients treated with cyclophosphamide-containing combination chemotherapy, a significantly reduced risk of death at five years was observed for GSTA1*B/*B patients compared with homozygous GSTA1*A patients. 15¥ This association was likely caused by decreased detoxification of the therapeutic metabolites of cyclophosphamide in GSTA1*B/*B patients. However, compared with GSTM1, GSTT1, and GSTP1, for which epidemiological studies are widely performed, alpha class GSTs have been little studied because functional polymorphisms have only recently been identified.
In this study, genetic variation in GSTA1 and GSTA2, which encode major isoforms of GSTA in human liver, were screened by sequencing 5$-regulatory regions and all the exons with their surrounding introns from 107 Japanese cancer patients who received oxaliplatin-based chemotherapy. LD and haplotype analyses were then performed using the detected variants, and haplotype-tagging single nucleotide polymorphisms ¤htSNPs¥ were identified to discriminate the common haplotypes in Japanese. Lastly, htSNPs of GSTA1 and GSTA2 were genotyped for an additional 107 Japanese patients using a single-base extension assay ¤SBE¥, which enabled us to rapidly and efficiently genotype them.
Materials and Methods
Human genomic DNA samples: All 214 colorectal cancer patients participating in this study were administered oxaliplatin-based chemotherapy at the National Cancer Center or Aichi Cancer Center. Genomic DNA was extracted from blood leukocytes from all subjects prior to the chemotherapy. The ethical review boards of the National Cancer Center, Aichi Cancer center, and the National Institute of Health Sciences approved this study. Written informed consent was obtained from all subjects.
GSTA1 DNA sequencing: The 5$-flanking region ¤up to 657 bp upstream from exon 1¥, all 7 exons with their surrounding introns, and the 3$-flanking region ¤up to 40 bp downstream from exon 7¥ were amplified by PCR and directly sequenced. For the first round of PCR, all regions except exon 4 were amplified by multiplex PCR using reaction mixtures contained 100 ng of genomic DNA, 1.25 units of Ex-Taq ¤Takara Bio. Inc. Shiga, Japan¥, 0.2 mM dNTPs, and 0.2 µM primers listed in Table 1 . The PCR conditions were 94ôC for 5 min; followed by 30 cycles of 94ôC for 30 s, 60ôC for 1 min, and 72ôC for 2 min; and then a final extension for 7 min at 72ôC. Exon 4 was singly amplified using identical conditions. In the second round of PCR, the first-round multiplex PCR products were separately amplified by nested PCR with Ex-Taq ¤1.25 units¥ and new primer sets ¤0.2 µM¥ under the same conditions. The final PCR products were then treated with a PCR Product Pre-Sequencing Kit ¤USB Co., Cleveland, OH, USA¥ and directly sequenced on both strands using an ABI BigDye Terminator Cycle Sequencing Kit ver. 3.1 ¤Applied Biosystems, Foster City, CA, USA¥ with the sequencing primers listed in Table 1 . Excess dye was removed by a DyeEx96 kit ¤Qiagen, Hilden, Germany¥. Eluates were analyzed on an ABI Prism 3730xl DNA Analyzer ¤Applied Biosystems¥. All novel SNPs were confirmed by repeated sequencing of the PCR products generated by new genomic DNA amplifications. The genomic and cDNA sequences of GSTA1 obtained from GenBank ¤NTð007592.14 and NMð145740.2, respectively¥ were used as reference sequences.
GSTA2 DNA sequencing: The 5$-flanking region ¤up to 985 bp upstream from exon 1¥, all 7 exons with their surrounding introns, and the 3$-flanking region ¤up to 128 bp downstream from exon 7¥ were sequenced. Briefly, the GSTA2 gene was amplified either by multiplex ¤exons 1, 2, The nucleotide position of the 5$ end of each primer on NTð007592.14.
b
From the translational start codon ¤ATG¥ in exon 2.
c For exon 4, the 1st PCR product was directly sequenced without the 2nd PCR.
3, 5, 6, and 7¥ or singleplex ¤exon 4¥ PCR from 100 ng of genomic DNA utilizing 1.25 units of Ex-Taq with 0.2 µM of primers listed in Table 2 ¤1st round PCR¥. In the second round PCR, all exons except for exon 4 were separately amplified from the first round PCR product by Ex-Taq ¤1.25 units¥ with 0.2 µM primers. All PCR conditions were the same as those described for GSTA1. PCR products were then directly sequenced with the primers listed under úsequencingû in Table 2 as described above for GSTA1. All novel SNPs were confirmed by repeated sequencing of PCR products that were newly generated by amplification of genomic DNA. The genomic and cDNA sequences of GSTA2 obtained from GenBank ¤NTð007592.14 and NMð000846.3, respectively¥ were used as reference sequences.
Linkage disequilibrium ¤LD¥ and haplotype analyses: Hardy-Weinberg equilibrium and LD analyses were performed by SNPAlyze software ¤Dynacom Co., Yokohama, Japan¥, and pairwise LD scores between variants were obtained for the qD$q and rho squared ¤r 2 ¥ values. Some of the haplotypes were unambiguous from subjects with homozygous variants at all sites or a heterozygous variant at only one site. The diplotype configurations were inferred by LDSUPPORT software, which determines the posterior probability distribution of the diplotype for each subject based on the estimated haplotype frequencies.
16¥
Genotyping by single nucleotide primer extension reaction: For typing 7 htSNPs in GSTA1, 4 genomic fragments were amplified by the two separate multiplex PCR reactions ¤multiplex 1 and multiplex 2, Table 1¥ . For GSTA2, three genomic regions containing 6 htSNPs in total were amplified simultaneously ¤Table 2¥. All reactions were performed in a volume of 25 µl containing 50 ng of genomic DNA, 0.1®0.6 µM primers, 0.2 mM dNTPs, and 0.625 units of Ex-Taq. The PCR conditions were as follows: 94ôC for 5 min; followed by 30 cycles of 94ôC for 30 s, 60ôC for The nucleotide position of the 5$ end of each primer on NTð007592.14.
c For exon 4, the 1st PCR product was directly sequenced without the 2nd PCR. The nucleotide that follows the translation termination codon TAA is numbered and starts as *1.
1 min, and 72ôC for 2 min; and then a final extension for 7 min at 72ôC. After amplification, excess primers and dNTPs were enzymatically removed by treating 5 µl of PCR product with 1.9 unit of Exonuclease I ¤USB Co.¥ and 0.19 unit of shrimp alkaline phosphatase ¤SAP, USB Co.¥ at 37ôC for 1 h and then at 80ôC for 15 min. For GSTA1, two separate single-base extension ¤SBE¥ assays were carried out for the above two multiplex PCR products using an ABI PRISM SnaPshot Multiplex Kit ¤Applied Biosystems¥. For GSTA2, the purified multiplex PCR product was subjected to two different SBE assays. The sequences of the typing primers with their final concentrations in the reaction mixture are also listed in Table 3 . Typing primers were designed to anneal to the target DNA immediately upstream of the each SNP site and to be extended by a single base at the polymorphic site in the presence of all four fluorescently labeled ddNTPs. Each SNP-specific primer was designed to be a different length by the addition of nonhomologous d¤GACT¥ polynucleotide tails of variable lengths to the 5$ end of the primer. This enabled differentiation of the SNP loci based on the length of the different ddNTP extended primers and facilitated the examination of 3®4 SNPs simultaneously.
All SBE reactions were performed in a volume of 10 µl containing 1 µl of purified PCR product, various concentrations of typing primers, and 5 µl of SnaPshot Multiplex Ready Reaction Mix. The reaction consisted of 25 cycles of 96ôC for 10 s, 50ôC for 5 s, and 60ôC for 30 s. The reaction products were then digested with 0.25 unit of SAP to inactivate unincorporated fluorescent ddNTPs at 37ôC for 1 h and then at 80ôC for 15 min. One microliter of the final product was denatured with 18.5 µl Hi-Di Formamide ¤Applied Biosystems¥ and 0.5 µl LiZ-120 Size Standards ¤Applied Biosystems¥ at 95ôC for 5 min. The fragments were then run on the 3130xl DNA Analyzer ¤Applied Biosystems¥ and genotyped using the GeneMapper software package ¤Applied Biosystems¥.
Results
Variants found in GSTA1 and GSTA2 genes: In GSTA1, 29 DNA sequence variants ¤9 novel¥ were found in the 107 Japanese subjects ¤Table 4¥. Of these variants, 5 map to the 5$-flanking region, 3 to the coding exons ¤3 synonymous variants¥, 19 to the introns, and 2 to the 3$-untranslated region ¤UTR¥. The detected variants were in Hardy-Weinberg equilibrium ¤p h 0.05 by the Û 2 test or Fisherös exact test¥, except for IVS4¦4ChT and IVS5-191ChT. Because both of these variants have low allele frequencies, the deviation from Hardy-Weinberg equilibrium was probably caused by the unexpected occurrence of only one more homozygote observed than expected in the 107 patients. All novel variants were found either in intronic regions or 3$-UTR at relatively low frequencies ¤g0.033¥, and no novel nonsynonymous SNPs were detected. Twenty other variants were previously reported or present in the dbSNP and/or JSNP databases. The reported SNPs of GSTA1*B, %567ThG ¤%5120 from the translational initiation site in Table 4¥ , %69ChT ¤%4622¥, and %52GhA ¤%4605¥, 8,17¥ were all found at allele frequencies of 0.140. Lower-case letters represent the nonhomologous tail at the 5$ end of the extension primer.
c
The electrophoretic mobility of the primer extension products is thought to correlate basically with the molecular weight of the typing primer plus the fluorescently labeled ddNTP incorporated at the 3$ end of primer. The nucleotide that follows the translation termination codon TAA is numbered and starts as *1.
c SNP positions were numbered based on proximal promoter sequences of GSTA1 according to Codes et al. ¤2001¥, and the transcription start site estimated by them was numbered ¦1.
d Allele frequencies were determined for the first 107 subjects examined by PCR-direct sequencing.
e Allele frequencies were determined for the total of 214 subjects examined by either PCR-direct sequencing ¤first 107 subjects¥ or by a single-base extension assay ¤additional 107 subjects¥. The nucleotide that follows the translation termination codon TAA is numbered and starts as *1.
c Allele frequencies were determined for the first 107 subjects examined by PCR-direct sequencing.
d Allele frequencies were determined for the total of 214 subjects examined by either PCR-direct sequencing ¤first 107 subjects¥ or by a single-base extension assay ¤additional 107 subjects¥.
In GSTA2, 27 genetic variants ¤17 novel¥ were detected: 6 were in the 5$-flanking region, 1 in the 5$-UTR, 4 in the coding exons ¤3 nonsynonymous and 1 synonymous¥, 15 in the introns, and 1 in the 3$-UTR ¤Table 5¥. All the detected variants were in Hardy-Weinberg equilibrium ¤p h 0.05¥. As was also the case for GSTA1, no novel nonsynonymous SNPs were detected in GSTA2. Three known nonsynonymous variants, 328ChT ¤Pro110Ser, *E¥, 335ChG ¤Thr112Ser, *A, *B, *D, and *E¥, and 629AhC ¤Glu210Ala, *B¥, were found at allele frequencies of 0.140, 0.294, and 0.154, respectively.
LD profile of GSTA1 and GSTA2: GSTA1 and GSTA2 are adjacently located in a head-to-tail orientation on chromosome 6p12, which spans approximately 28 kb. Therefore, we analyzed LD profiles of the SNPs detected in both GSTA1 and GSTA2 ¤Fig. 1¥. Of all the 378 pairwise qD$q values between 28 common SNPs ¤16 in GSTA1 and 12 in GSTA2, allele frequencies h0.03¥, 354 pairs ¤94%¥ had qD$q h 0.90 ¤data not shown¥, indicating an extended LD block covering both GSTA1 and GSTA2. Perfect LD ¤r 2 © 1.0¥ was observed among 14 SNPs ¤10 in GSTA1 and 4 in GSTA2¥: %5120¤%567¥ThG, %5066¤%513¥AhG, %4622¤%52¥ChT, %4605¤%52¥GhA, IVS2¦113GhT, IVS2¦166ThC, IVS2 % 452AhC, IVS4 % 103AhC, 375AhG ¤Lys125Lys¥, IVS5 % 406ThC ¤in GSTA1¥, %5806ChT, IVS1 % 39AhG, IVS2¦184AhC, and 328ChT ¤Pro110Ser¥ ¤in GSTA2¥. Two ¤IVS4¦113AhG in GSTA1 and 335ChG ¤Thr112Ser¥ in GSTA2¥ and three ¤%10GhC, IVS4 % 160AhG, and 629AhC ¤Glu210Ala¥ in GSTA2¥ SNPs were also in perfect LD ¤r 2 © 1.0¥. In addition, three SNPs in GSTA1 ¤IVS2%324AhC, IVS2%280 ThC, and IVS2%267ChT¥ were also perfectly linked ¤r 2 © 1.0¥, although their frequencies were low ¤0.019¥.
Haplotype estimation and selection of haplotype-tagging SNPs ¤htSNPs¥:
First, the haplotype structures of the two genes were analyzed using all the detected SNPs. In GSTA1, 20 haplotypes were inferred using 29 SNPs. As shown in Figure 2 , the haplotypes |D'|  -5184G>T  -5120T>G  -5066A>G  -4622C>T  -4605G>A  IVS2+113G>T  IVS2+166T>C  IVS2-452A>C  IVS2-23G>A  IVS4+4C>T  IVS4+113A>G  IVS4+251C>T  IVS4- -5120T>G  -5066A>G  -4622C>T  -4605G>A  IVS2+113G>T  IVS2+166T>C  IVS2-452A>C  IVS2-23G>A  IVS4+4C>T  IVS4+113A>G  IVS4+251C>T  IVS4-103A>C   375A>G (Lys125Lys)  IVS5-406T>C  *187T>A  -6066A>T  -5806C>T  -5750_-5749insAAT  IVS1-39A>G  -10G>C  IVS2+184A>C  IVS4-160A>G 328C>T ( corresponding to *A were designated as *1, and their subtypes were named by use of alphabetical lower-case letters in the order of their frequencies ¤*1a to *1q¥. The *2 group ¤*2a to *2c¥ was defined as the haplotypes corresponding to *B and harbored the known functionally relevant SNPs %567¤%5120¥ThG, %69¤%4622¥ChT, and %52¤%4605¥GhA. 8¥ The most frequent haplotype was *1a ¤0.285 in frequency¥, followed by *1b ¤0.215¥, *1c ¤0.145¥, *2a ¤0.089¥, *2b ¤0.047¥, and *1e ¤0.033¥. These six haplotypes accounted for 81% of all haplotypes. Although a large number of haplotypes were inferred, they were classified into only 8 major haplotype groups: GSTA1#1A, #1B, #1C, #1D, #1E, #1I, #2A, and #2B ¤Fig. 2¥. The htSNPs selected were %5184GhT ¤the tag for *1a, *1d, *1e, and *1i¥, IVS2%452AhC ¤for *2a and *2b¥, IVS2%324AhC ¤for *1i¥, IVS4¦4ChT ¤for *1d¥, IVS4¦113AhG ¤for *1c, *2a, and *2b¥, IVS4¦251ChT ¤for *2a¥, and *187ThA ¤for *1e¥. These htSNPs can resolve the 8 haplotype groups ¤GSTA1#1A, #1B, #1C, #1D, #1E, #1I, #2A, and #2B¥. Although the causative SNP for the low hepatic expression of GSTA1*B was suggested to be %52¤%4605¥GhA ¤see Discussion¥, we chose the perfectly linked SNP IVS2%452AhC as the htSNP of GSTA1*2 for the convenience of the genotyping described below.
For the GSTA2 gene, 20 haplotypes were identified or inferred using the 27 variants ¤Fig. 3¥. As shown in Figure 3 , 15 haplotypes without any amino acid changes were designated as GSTA2*1, and correspond to GSTA2*C as designated by Tetlow et al. 9¥ The haplotypes with the known nonsynonymous SNP were numbered. Three *2 haplotypes ¤GSTA2*2a, *2b, and *2c¥ harboring 335ChG ¤Thr112Ser¥ and 629AhC ¤Glu210Ala¥ and two *3 haplotypes ¤GSTA2*3a and *3b¥ harboring 328ChT ¤Pro110Ser¥ and 335ChG ¤Thr112Ser¥ were assigned, and they correspond to GSTA2*B and GSTA2*E, respectively. 9,10¥ Neither GSTA2*A ¤Pro110, Ser112, Lys196, and Glu210¥ nor GSTA2*D ¤Pro110, Ser112, Asn196, and Ala210¥ were found in this study. The most frequent haplotype was *1a ¤0.551 frequency¥, followed by *3a ¤0.131¥, *2a ¤0.112¥, *1b ¤0.042¥, *1c ¤0.033¥, and *2b ¤0.033¥. These six haplotypes account for 90% of all haplotypes. The htSNPs selected were %6066AhT ¤the tag for *1c¥, 328ChT ¤Pro110Ser¥ ¤for *3a¥, 335ChG ¤Thr112Ser¥ ¤for *2a, *2b, and *3a¥, IVS5¦152ThC ¤for *2b¥, 629AhC ¤Glu210Ala¥ ¤for *2a and *2b¥, and 814 ¤*145¥ChA ¤for *1b¥. These SNPs can resolve the 6 haplotype groups: three *1 groups ¤GSTA2#1A, #1B, and #1C¥, two *2 groups ¤GSTA2#2A and #2B¥, and one *3 group ¤GSTA2#3A¥.
Genotyping of htSNPs of GSTA1 and GSTA2: To genotype the 13 htSNPs of GSTA1 and GSTA2 identified above in a cost-effective manner, we designed single-base extension assays ¤SBE¥ for each. Figure 4 shows the representative electropherograms of 4 multiplex minisequencing reactions ¤GSTA1-Mix 1, GSTA1-Mix 2, GSTA2-Mix 1, and GSTA2-Mix 2¥. In a sample homozygous for a particular SNP, one of the four dye-terminators is extended to the SNP-specific primer, producing a single elongated primer peak. In a heterozygous sample, two peaks are produced with different dye-terminators. Genotyping of the 13 htSNPs using this method resulted in 100% (P5P)  IVS2+55C>T  IVS2+113G>T  IVS2+166T>C  IVS2-452A>C  ¶  IVS2-324A>C  ¶  IVS2-280T>C  IVS2-267C>T  IVS2-23G>A  IVS3+11T>C  IVS3+64C>T  IVS4+4C>T  ¶  IVS4+83G>A  IVS4+113A>G  ¶  IVS4+251C>T  ¶  IVS4-103A>C   375A>G (K125K)  IVS5-468A>G  IVS5-406T>C  IVS5-191C>T 429T>C ( concordance with the direct sequencing findings. We then genotyped the 13 htSNPs in an additional set of 107 patients.
The allele frequencies of all 13 htSNPs in a total of 214 cancer patients are summarized in Table 4 ¤GSTA1¥ and Table 5 ¤GSTA2¥. All the allele frequencies obtained from the total of 214 patients were in Hardy-Weinberg equilibrium. Long-range haplotypes spanning GSTA1 and GSTA2: Since strong LD was observed throughout GSTA1 and GSTA2 ¤Fig. 1¥, the long-range haplotypes spanning the two genes were inferred for the 214 patients using the 13 htSNPs, which could resolve the 8 and 6 haplotype groups in GSTA1 ¤GSTA1#1A, #1B, #1C, #1D, #1E, #1I, #2A, and #2B¥ and GSTA2 ¤GSTA2#1A, #1B, #1C, #2A, #2B, and #3A¥, respectively ¤Fig. 5¥. The most frequent haplotype ¤haplotype frequency © 0.269¥ was the combination of GSTA1#1B-GSTA2#1A, and the second most frequent was GSTA1#1A-GSTA2#1A ¤0.262¥. These two major combinations corresponded to the previously reported combination, GSTA1*A-GSTA2*C. The third most frequent combination, GSTA1#1C-GSTA2#2A ¤0.150¥, corresponded to GSTA1*A-GSTA2*B. The next most frequent combinations GSTA1#2A-GSTA2#3A ¤0.089¥ and GSTA1#2B-GSTA2#3A ¤0.044¥ corresponded to GSTA1*B-GSTA2*E. Consequently, GSTA1 and GSTA2 haplotype combinations in this Japanese population were classified into the 3 major types according to the reported designation: GSTA1*A-GSTA2*C, GSTA1*A-GSTA2*B, and GSTA1*B-GSTA2*E ¤Fig. 5¥.
Discussion
The present study provides the first comprehensive data for Japanese on genetic variation of GSTA1 and GSTA2, which encode the phase II metabolic enzymes important for cellular detoxication systems. Moreover, LD profiles and haplotype structures covering the two genes were identified, and a haplotyping strategy using tagging SNPs was established.
In 107 Japanese patients, no novel nonsynonymous SNPs were detected in either GSTA1 or GSTA2 by direct sequencing, but several functional SNPs previously reported were detected. In the study population, the allele frequency of GSTA1*2 ¤named GSTA1*B by Coles et al. 8¥ ¥, which harbors 3 linked SNPs in the proximal promoter ª%5120¤%567¥ThG, %4622¤%69¥ChT, and %4605¤%52¥GhA«, was 0.140, which was comparable to that ¤0.16¥ previously obtained in 147 Japanese subjects.
18¥
Compared with Japanese populations, GSTA1*B is found more frequently in Caucasians ¤0.432¥ and AfricanAmericans ¤0.357¥. 10¥ As for other populations, the SNP500Cancer project ¤http://variantgps.nci.nih.gov/ cgfseq/pages/snp500.do¥ showed that the allele frequencies of %4605¤%52¥GhA, the SNP causative for low expression of GSTA1*B, in African-American, Caucasian, Hispanic, and Pacific Rim populations were 0.417, 0.387, 0.326, and 0.292, respectively. The %4605¤%52¥GhA substitution in an SP1-responsive element within the proximal promoter has been shown to cause 4-fold lower promoter activity -10G>C  IVS2+184A>C  IVS3+73C>A  IVS3+231C>T  IVS3+232C>G  IVS3+334A>C  IVS3-61_60insT  IVS4-160A>G  IVS4-10delT 328C>T ( Fig. 3 . GSTA2 haplotypes in a Japanese population Each haplotype is shown in a separate row, and the SNPs are shown in the columns; white cells indicate major alleles and gray cells indicate minor alleles (nucleotide alteration). The haplotypes inferred in only one patient are ambiguous and are indicated with a question mark.
¶ Six haplotype-tagging SNPs (htSNPs) for this Japanese population.
§ Haplotypes tagged by the 6 htSNPs. GSTA1#1A-GSTA2#1A  GSTA1#1B-GSTA2#1A  GSTA1#1A-GSTA2#1B  GSTA1#1A-GSTA2#1C  GSTA1#1D-GSTA2#1A  GSTA1#1E-GSTA2#1A  GSTA1#1I-GSTA2#1A  GSTA1#1C-GSTA2#2A  GSTA1#1C-GSTA2#2B  GSTA1#2A-GSTA2#3A  GSTA1#2B- . Long-range haplotypes spanning GSTA1 and GSTA2 Long-range haplotypes were inferred using the 13 htSNPs, which could resolve the 8 and 6 haplotype groups in GSTA1 (GSTA1#1A, #1B, #1C, #1D, #1E, #1I, #2A, and #2B in Fig. 2 ) and GSTA2 (GSTA2#1A, #1B, #1C, #2A, #2B, and #3A in Fig. 3 ), respectively. Each haplotype combination is shown in a separate row, and htSNPs are shown in the columns with white cells being the major alleles and gray cells being the minor alleles (nucleotide alteration). Because of the perfect linkage between −52(−4605)GhA and IVS2−452AhC in this Japanese population, IVS2−452AhC was selected as a htSNP of GSTA1*B, named by Coles et al. Fig. 4 . Genotyping of representative sample at the 13 htSNP sites of GSTA1 and GSTA2 The electropherograms of 4 multiplex minisequencing reactions (GSTA1-Mix 1, GSTA1-Mix 2, GSTA2-Mix 1, and GSTA2-Mix 2) to genotype 13 htSNPs are shown. Each fluorescent ddNTP emits a different wavelength, which is translated into a specific color for each base (ddATP, ddCTP, ddGTP, and ddTTP are green, black, blue, and red, respectively). The colored boxes (green, yellow, blue, and red) around the peaks indicate the bins for the automatic allele calling. Peaks in orange were standards for migration length.
8)
in vitro. 4¥ A weak correlation has been observed between the protein levels of GST alpha in gastric cancer tissues and cisplatin resistance. 19¥ We are now planning to examine the impact of this allele on the efficacy and toxicity of oxaliplatin.
In GSTA2, the previously reported allelic variants GSTA2*B ª328C ¤Pro110¥, 335G ¤Ser112¥, 588G ¤Lys196¥, and 629C ¤Ala210¥«, GSTA2*C ª328C ¤Pro110¥, 335C ¤Thr112¥, 588G ¤Lys196¥, and 629A ¤Glu210¥«, and GSTA2*E ª328T ¤Ser110¥, 335G ¤Ser112¥, 588G ¤Lys196¥, and 629A ¤Glu210¥« were detected at frequencies of 0.154, 0.706, and 0.140, respectively; these correspond to GSTA2*2, GSTA2*1, and GSTA2*3 in our haplotype definition ¤Fig. 3¥. In contrast, GSTA2*A ª328C ¤Pro110¥, 335G ¤Ser112¥, 588G ¤Lys196¥, and 629A ¤Glu210¥« and GSTA2*D ª328C ¤Pro110¥, 335G ¤Ser112¥, 588T ¤Asn196¥, and 629C ¤Ala210¥« were not detected in this study. The absence of GSTA2*D was consistent with a previous report that this allele was identified only in the expressed sequence tag ¤EST¥ clone. 9¥ The distribution of GSTA2*A, *B, *C, and *E differed considerably among various ethnic groups when data of the International HapMap Project ¤http:// www.hapmap.org/index.html.ja¥ and SNP500Cancer ¤http://variantgps.nci.nih.gov/cgfseq/pages/snp500.do¥ were used for comparison ¤data not shown¥. Compared with Caucasians, in which GSTA2*A and GSTA2*E were detected at frequencies of 0.3 and 0.05, respectively, 20¥ the absence of GSTA2*A and more frequent occurrence of GSTA2*E were characteristic of Japanese. In Asians, the frequency of GSTA2*E in this study ¤0.140¥ was comparable to that of Chinese ¤0.12¥ reported by Tetlow and Board. 11¥ On the other hand, the considerable differences in the frequencies of GSTA2*A and GSTA2*C between Japanese ¤frequency: GSTA2*A, 0.000; GSTA2*C, 0.706 in this study¥ and Chinese ¤frequency: GSTA2*A, 0.70; GSTA2*C, 0.00 in the study by Tetlow and Board 11¥ ¥ might be due to a sequencing error resulting from non-GSTA2-specific amplification in the study by Tetlow and Board, which has already been pointed out by Ning et al. 10¥ It has been reported that GSTA2A, GSTA2B, and GSTA2C enzymes do not appear to differ in their catalytic properties, while GSTA2E shows reduced specific activities toward the classic GST substrate CDNB and organic hydroperoxides such as arachidonic acid hydroperoxide but an increased specific activity toward p-nitrophenol acetate.
10,11¥ Further analysis is needed to establish the association of GSTA2*E with oxaliplatin pharmacodynamics.
It has been shown that GSTA1*A and *B are associated with high and low hepatic expression of GSTA1, respectively, 8¥ and that the GSTA2 335C ¤Thr112, GSTA2*C¥ and 335G ¤Ser112, GSTA2*A, *B, or *E¥ are associated with low and high hepatic expression of GSTA2, respectively.
